Cart

0

Business

“Swiss pharma giant Roche agrees $7.1 billion deal to buy Telavant Holdings”

“Swiss health care company Roche on Monday announced it would acquire Telavant Holdings in a $7.1 billion transaction. Telavant produces drugs for people suffering from inflammatory and fibrotic diseases and is in the process of developing a “promising new therapy”… Continue Reading…